After Hours
$
241.85
Change
+0.10 +0.04%
Volume
Volume 216,477
Mar 31, 2023, 7:59 p.m.
Quotes are delayed by 20 min
Previous close
$ 241.50
$ 241.75
Change
+0.25 +0.10%
Day low
Day high
$239.15
$242.40

52 week low
52 week high
$223.30
$296.67

Market cap
$129.09B
Average volume
2.61M
P/E ratio
19.96
Rev. per Employee
$1.04M
EPS
12.11
Dividend
2.13
Div yield
3.52%
Ex dividend date
5/17/23
MarketWatch News on AMGN
-
Here are the 20 best performing stocks of March — and the 20 worst
- Philip van Doorn
-
Amgen, Procter & Gamble share gains contribute to Dow's 100-point jump
- MarketWatch Automation
-
Amgen, Procter & Gamble share gains lead the way, but Dow flat
- MarketWatch Automation
-
Microsoft, Amgen share gains lead the way, but Dow flat
- MarketWatch Automation
-
Amgen, Microsoft share gains contribute to Dow's nearly 100-point climb
- MarketWatch Automation
-
Dow jumps nearly 200 points on gains for Amgen, Microsoft stocks
- MarketWatch Automation
-
Amgen, Procter & Gamble share gains lead Dow's 90-point climb
- MarketWatch Automation
-
Amgen, Procter & Gamble share gains lead the way, but Dow flat
- MarketWatch Automation
-
These stocks fared the worst as Powell pushed the market down Tuesday
- Philip van Doorn
-
The 20 worst U.S. stocks in February: the biggest loser dropped 35%
- Philip van Doorn
-
Biosimilar Pricing Looks a Mess. Why Costly Drugs Prevail.
- Josh Nathan-Kazis
-
Dow's 60-point jump led by gains for Amgen, Merck stocks
- MarketWatch Automation
-
Dow's 139-point drop led by losses for Microsoft, Amgen stocks
- MarketWatch Automation
- Loading more headlines...
Analyst Ratings
-
Analysts Raise Ratings on Teva Stock on Ajovy’s FDA Approval
- MarketRealist.com
-
Analysts’ Latest Recommendations on Mylan
- MarketRealist.com
-
Analysts Raise Their 12-Month Target Price on Teva Pharmaceutical
- MarketRealist.com
Other News on AMGN
-
Amgen Seeks to Monopolize Nature
- Gregory Winter
-
Eli Lilly Is Priced for Perfection in the Obesity Market
- David Wainer
-
Pfizer Overpays for Seagen, but Who’s Counting
- David Wainer
-
Top 5 4th Quarter Trades of Palouse Capital Management, Inc.
- GuruFocus.com
-
Top 5 4th Quarter Trades of BERKSHIRE ASSET MANAGEMENT LLC/PA
- GuruFocus.com
-
FEDERATED HERMES, INC. Buys 1, Sells 4 in 4th Quarter
- GuruFocus.com
-
Palouse Capital Management, Inc. Buys 2, Sells 3 in 4th Quarter
- GuruFocus.com
-
Top 5 4th Quarter Trades of Compagnie Lombard Odier SCmA
- GuruFocus.com
-
Exxon Is an Exile on Wall Street and Loving It
- Spencer Jakab
-
Dow Sits Out Stock Market’s Wild Ride
- Charley Grant
-
- Edgar Online - (EDG = 10Q, 10K)
-
Pfizer, Novartis, Merck Executives Say They Are Hunting for Deals Again
- Jared S. Hopkins
-
AbbVie Aims for New Drugs to Boost Sales
- Jared S. Hopkins
-
Capital Wealth Planning, LLC Buys 2, Sells 3 in 4th Quarter
- GuruFocus.com
-
Top 5 4th Quarter Trades of First Dallas Securities Inc.
- GuruFocus.com
-
Drug Prices Rise 5.6% as U.S. Ramps Up Pressure to Lower Costs
- Jared S. Hopkins
- Loading more headlines...
Press Releases on AMGN
-
- Newsfile Corp
-
- Newsfile Corp
-
- Newsfile Corp
-
Amgen Shareholder Action Reminder
- Newsfile Corp
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com